Greenidge to sell Mississippi mining unit for $3,9 million
- Greenidge sells bitcoin mining facility in Mississippi
- Financial difficulties and Trump's tariffs affect mining companies
- US environment reduces competitiveness in bitcoin mining
Greenidge Generation, a Nasdaq-listed bitcoin mining company, announced the sale of its Columbus, Mississippi, facility for $3,9 million. The structure, which occupies 6,4 acres, will be acquired by US Digital Mining Mississippi, an affiliate of rival LM Funding America. The transaction comes just one year after the site began operations.
According to the document filed with the SEC, the sale includes operating contracts, equipment, and commercial assets, but excludes mining machinery currently in use and a 73-square-foot warehouse, which may be sold separately. The deal is expected to close on September 16, subject to customary conditions.
The facility opened in July 2024 with 2.400 miners relocated from other company centers, along with plans to expand power capacity from 8,5 MW to 33,5 MW. At the time, CEO Jordan Kovler stated, "As we continue to expand our footprint across the country, we are actively evaluating new strategic opportunities to develop, purchase, lease, or, where appropriate, sell properties aligned with our value creation playbook."
The decision to sell reflects the ongoing financial pressure Greenidge has faced since its aggressive, debt-driven expansion in 2021. Despite attempts to scale back operations, the company remains impacted by the low economic returns from post-halving mining, exacerbated by the historically low hash price, even with Bitcoin above $116.
Furthermore, the regulatory environment in the United States has become more stringent for mining companies. New import tariffs imposed by President Donald Trump in August have significantly increased the costs of equipment from Southeast Asia, reducing the competitiveness of the domestic sector. North American mining companies are now considering alternatives abroad while waiting for domestic production capacity to strengthen.
Despite the challenges, Greenidge remains among the top 20 publicly traded bitcoin miners, although it lags behind market leader MARA, which is valued at $5,9 billion.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify
In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Crypto prices
More
